Enterprise record

ARTIVION, INC. logo

ARTIVION, INC.

Public governance Claims and source records for this enterprise.

Follow
More
Reports & analysis (Directory temporarily unavailable)Alpha EvalSave PDFCompareChallenge a ClaimClaim this record

Alpha ID: alpha:company:0d51d469-7ad5-4e65-8752-b9f915967709Version: public-1As of: unavailable

23 published Claims3 sources

Key Claims

Board and committees

Source-backed public-market identity

Index memberships

Current memberships are attached to a specific security and listing. Announcements, effective dates, and removals remain distinct states; Alpha does not infer membership from company size, exchange, or reputation.

No current membership is published in Alpha's tracked index universe.

This is not evidence that the company is absent from every market index.

As of Sep 30, 2026. Rights-filtered public evidence only; no redistribution or model training is granted.

Only source-backed memberships with an explicit public redistribution basis are returned.

Evidence, history and coverage

Additional published Claims

Published evidence records

3 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. Alpha canonical company public projection

    canonical identity · Source published: Date unavailable · Retrieved: Sep 29, 2026

    Supports 3 claims
    • Legal Name: ARTIVION, INC. · Claim reviewed: Sep 29, 2026
    • Entity Status: Public listing published · Claim reviewed: Sep 29, 2026
    • Published Fact: US · Claim reviewed: Sep 29, 2026

  2. ARTIVION, INC. DEF 14A 2026-04-01

    sec proxy · Source published: Apr 1, 2026 · Retrieved: Apr 24, 2026

    Supports 8 claims
    • Leadership Role: Daniel J. Bevevino: Director · Claim reviewed: Sep 29, 2026
    • Leadership Role: Elizabeth A. Hoff: Director · Claim reviewed: Sep 29, 2026
    • Leadership Role: J. Patrick Mackin: Director · Claim reviewed: Sep 29, 2026
    • Leadership Role: James W. Bullock: Director · Claim reviewed: Sep 29, 2026
    • Leadership Role: Jeffrey H. Burbank: Director · Claim reviewed: Sep 29, 2026
    • Leadership Role: Jon W. Salveson: Director · Claim reviewed: Sep 29, 2026
    • Leadership Role: Marna P. Borgstrom: Director · Claim reviewed: Sep 29, 2026
    • Leadership Role: Thomas F. Ackerman: Director · Claim reviewed: Sep 29, 2026

  3. AORT 10-K executive officers

    sec filing · Source published: Feb 18, 2026 · Retrieved: May 14, 2026

    Supports 12 claims
    • Leadership Role: Amy D. Horton: Vice President, Chief Accounting Officer · Claim reviewed: Sep 29, 2026
    • Leadership Role: Andrew M. Green: Senior Vice President, Regulatory and Quality · Claim reviewed: Sep 29, 2026
    • Leadership Role: Florian Tyrs: Vice President, Global Operations · Claim reviewed: Sep 29, 2026
    • Leadership Role: J. Patrick Mackin: Chairman, President, and Chief Executive Officer · Claim reviewed: Sep 29, 2026
    • Leadership Role: Jason Asper: Senior Vice President and Chief Strategy and Digital Officer · Claim reviewed: Sep 29, 2026
    • Leadership Role: Jean F. Holloway: Senior Vice President, General Counsel, Chief Compliance Officer, and Corporate Secretary · Claim reviewed: Sep 29, 2026
    • Leadership Role: John E. Davis: Chief Commercial Officer · Claim reviewed: Sep 29, 2026
    • Leadership Role: Lance A. Berry: Executive Vice President, Chief Operating Officer, Chief Financial Officer and Treasurer · Claim reviewed: Sep 29, 2026
    • Leadership Role: Marshall S. Stanton: Senior Vice President, Clinical Research and Chief Medical Officer · Claim reviewed: Sep 29, 2026
    • Leadership Role: Matthew A. Getz: Vice President, Human Resources · Claim reviewed: Sep 29, 2026
    • Leadership Role: Robert C. Thomson: Vice President, Research and Development · Claim reviewed: Sep 29, 2026
    • Leadership Role: Rochelle L. Maney: Vice President, Quality Systems and Tissue Quality · Claim reviewed: Sep 29, 2026